Clinical trial

Shorter Radiation Schedule for the Treatment of Prostate Cancer

NCT00201916

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention 5250 cGy/20 fractions over 28 days Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention 6600 cGy/33 fractions over 45 days Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Shorter Radiation Schedule for the Treatment of Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1995-03-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

5250 cGy/20 fractions over 28 daysPROCEDURE

6600 cGy/33 fractions over 45 daysPROCEDURE

Sponsors & collaborators

Ontario Clinical Oncology Group (OCOG)lead sponsor

NCIC Clinical Trials Groupcollaborator

Mapped research locations

TorontoOntario, Canada2 VancouverBritish Columbia, Canada1 LondonOntario, Canada1 HamiltonOntario, Canada1 WinnipegManitoba, Canada1 HalifaxNova Scotia, Canada1 KingstonOntario, Canada1 SaskatoonSaskatchewan, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00201916 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.